Short Interest in InterCure Ltd. (NASDAQ:INCR) Expands By 24.5%

InterCure Ltd. (NASDAQ:INCR) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 34,100 shares, an increase of 24.5% from the March 15th total of 27,400 shares. Based on an average daily volume of 20,800 shares, the short-interest ratio is currently 1.6 days. Approximately 0.1% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in INCR. Virtu Financial LLC bought a new stake in shares of InterCure during the third quarter worth $43,000. Jane Street Group LLC acquired a new position in InterCure in the 3rd quarter worth about $49,000. Finally, Moore Capital Management LP acquired a new stake in shares of InterCure during the fourth quarter valued at about $156,000. Institutional investors own 8.34% of the company’s stock.

InterCure Trading Down 1.8 %

Shares of INCR stock traded down $0.03 during trading hours on Monday, reaching $1.35. The company’s stock had a trading volume of 5,126 shares, compared to its average volume of 34,771. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. InterCure has a fifty-two week low of $1.17 and a fifty-two week high of $3.72. The firm’s 50 day simple moving average is $1.49 and its 200-day simple moving average is $1.56.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.